Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product

FDA Comment Number :

EC984

Submitter :

Mr. Lenny Marano

Date & Time:

10/27/2005 09:10:55

Organization :

Mr. Lenny Marano

Category :

Individual Consumer

Issue Areas/Comments

GENERAL

GENERAL

I am writing to express my oppositon to any delay that would prevent women and women who are victims of sexual assualt from havig immediate and unfettered access to emergency contraception. I therefore urge the FDA to again follow the recommendations of the FDA's advisory panel that EC be available without any restrictions.